Head-to-head · Cost-Efficiency Index
Hello Alpha vs InstaRX
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Hello Alpha
Cost-first shoppers who want existing or prospective Hello Alpha women's-health patients who want branded (not compounded) GLP-1 prescribing folded into the same platform.
Visit Hello AlphaInstaRX
Cost-first shoppers who want one flat price at every dose, for shoppers who don't want to guess what a dose increase will cost.
Visit InstaRXThe verdict
Hello Alpha and InstaRX tie on the Cost-Efficiency Index at 67/100, so neither wins outright on the numbers. For most shoppers we'd start with Hello Alpha (ranked #138, a hair above #139) — Cost-first shoppers who want existing or prospective Hello Alpha women's-health patients who want branded (not compounded) GLP-1 prescribing folded into the same platform. But InstaRX is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Hello Alpha.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Hello Alpha | InstaRX |
|---|---|---|
| Cost-Efficiency Index | 67/100 | 67/100 |
| Semaglutide / mo | $79/mo (brand Wegovy, plus a separate fee) | $179/mo |
| Tirzepatide / mo | $79/mo (brand Mounjaro, plus a separate fee) | $259/mo |
| Semaglutide / yr (modeled) | $948 | $2,148 |
| Tirzepatide / yr (modeled) | $948 | $3,108 |
| Coverage | Coverage not published | All 50 states |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #138 | #139 |
Hello Alpha
67/100Where the value is
- Only prescribes FDA-approved branded GLP-1s (no compounding risk/variability)
- Established, well-known women's telehealth brand with a named Chief Medical Officer (Dr. Loni Belyea)
- Broad medication menu includes newer options like oral orforglipron (Foundayo)
The tradeoffs
- The $79/mo headline figure is a membership fee, NOT the drug price
- Site explicitly states a prescription is not guaranteed by membership
InstaRX
67/100Where the value is
- Flat 'same price any dose' model for both drugs ($179/mo semaglutide, $259/mo tirzepatide) — no dose-tier guesswork
- Free expedited shipping stated explicitly
- States medications come 'exclusively from U.S. pharmacies'
The tradeoffs
- The homepage's own '$199 to get started' figure is never explained anywhere on the site — unclear if it's a one-time signup charge, the first month's payment, or an additional charge on top of the $179/$259 monthly prices
- No medical director or named prescriber anywhere — only generic 'third-party professional healthcare providers' language
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.